Health-related quality of life for patients with chronic lymphocytic leukaemia - A critical outcome measure in the era of highly effective therapies
- Author(s)
- Lew, TE; Anderson, MA;
- Details
- Publication Year 2022-05,Volume 197,Issue #4,Page 394-396
- Journal Title
- British Journal of Haematology
- Publication Type
- Commentary
- Publisher
- Wiley
- Keywords
- Bridged Bicyclo Compounds, Heterocyclic; Humans; *Leukemia, Lymphocytic, Chronic, B-Cell/therapy; Outcome Assessment, Health Care; Quality of Life; Sulfonamides; Bruton tyrosine kinase inhibitors; chronic lymphocytic leukaemia; quality of life, venetoclax
- Department(s)
- Haematology
- PubMed ID
- 35262916
- Publisher's Version
- https://doi.org/10.1111/bjh.18118
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-01-17 02:00:48
Last Modified: 2025-01-17 02:02:19